The global Network Point-Of-Care Glucose Testing
Market size is expected to reach USD 1.6 billion by
2028, according to a new report by Grand View Research, Inc. It is expected to
expand at a CAGR of 3.9% from 2021 to 2028. Increasing demand for safe and
accurate remote patient monitoring options and the need for data-based
treatment regimens are major factors driving the market. The integration of
advanced technologies including Bluetooth Low Energy (BLE) and Infrared is
expected to fuel the market growth in the upcoming years.
Expanding patient base in Asia Pacific and the
Middle East and the high demand for advanced diabetes management systems are
creating significant growth opportunities in these regions. These regions also
include some of the highly preferred destinations for medical tourism.
Increasing demand for world-class healthcare services and rising adoption of
advanced technology are some of the factors boosting the market growth in these
regions.
Network point-of-care glucose meters were
extensively used in COVID-19 care. This enabled doctors to remotely observe
glucose levels with minimal risk of infection. In addition, a large amount of
data is still being used to customize treatment plans for diabetic COVID-19
patients. Preference for telemedicine and trends of home healthcare settings
for chronic patients are some of the factors expected to expand the
applications of network-based point-of-care devices.
List of Key Players of Network Point-of-Care Glucose
Testing Market
- F. Hoffmann-La Roche Ltd.
- Abbott
- Nova Biomedical
- Bayer AG/Ascensia Diabetes Care Holdings AG
- Danaher
Related Reports@ Network Point-of-Care Glucose Testing
Market Report
Network Point-of-Care Glucose Testing Market Report
Highlights
- Network point-of-care devices were in high demand during the first
and second wave of COVID-19 owing to their advantage of remote patient
monitoring
- Based on product, the Accu-Chek Inform II segment held the largest
revenue share in 2020 and is expected to expand at a lucrative growth rate
during the forecast period
- North America held the largest revenue share in 2020 and is
predicted to maintain its lead over the forecast period owing to the
factors such as the presence of major players and high adoption rate
Related Reports@
Point-of-Care Glucose Testing Market
Blood Glucose Monitoring Devices Market
Network Point-of-Care Glucose Testing Market
Report Scope
|
Report Attribute |
Details |
|
Market size value in 2021 |
USD 1.2 billion |
|
Revenue forecast in 2028 |
USD 1.6 billion |
|
Growth Rate |
CAGR of 3.9% from 2021 to 2028 |
|
Base year for estimation |
2020 |
|
Historical data |
2016 - 2019 |
|
Forecast period |
2021 - 2028 |
Network Point-of-Care Glucose Testing Market Segmentation
Grand View Research has segmented the global network
point-of-care glucose testing market on the basis of product, and region:
Network Point-of-Care Glucose Testing Product Outlook
(Revenue, USD Million, 2016 - 2028)
- i-STAT
- Accu-Chek Inform II
- StatStrip
- HemoCue
- CareSens Expert Plus
- BAROzen H Expert Plus
Network Point-of-Care Glucose Testing Regional Outlook
(Revenue, USD Million, 2016 - 2028)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment